Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

HEM.V Relative to the S&P 500

HEM.V Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Hemostemix Inc. (TSXV:HEM.V) seasonal charts above shows that a Buy Date of August 2 and a Sell Date of October 21 has resulted in a geometric average return of 19.47% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 58.8% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Hemostemix Inc is a biotechnology company. The company’s principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company’s technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company’s clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.

To download HEM.V seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: HEM.V